`
`From:
`Sent:
`To:
`Subject:
`Attachments:
`
`Dowd, Matthew J <MatthewDowd@andrewskurth.com>
`Thursday, May 26, 2016 12:10 PM
`Reister, Andrea
`Argentum v. UCB, IPR2016-00204
`IPR2014-00244 (denying joinder when first petition settled).pdf; Mylan Vimpat IPR
`joinder motion 5-25-16.pdf; Settlement Term Sheet - UCBVimpat 5-26-16.pdf
`
`Andrea:
`
`In view of the Board’s decision to institute trial, I provide an updated settlement term sheet for your and your client’s
`consideration. Additionally, as you may know, Mylan Pharmaceuticals has filed its own IPR petition and a motion for
`joinder. Notwithstanding Mylan’s petition and motion, Argentum remains amenable to amicably resolving the pending
`IPR with UCB. We provide, for your convenience, an exemplary Board decision denying joinder where the first petitioner
`settled prior to a decision on the joinder motion.
`
`We look forward to your response.
`
`Best regards,
`
`Matthew J. Dowd
`Partner
`
`Andrews Kurth LLP
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`202.662.2701 Phone
`202.974.9511 Fax
`202.573.3853 Cell
`MatthewDowd@andrewskurth.com
`vCard | Bio | andrewskurth.com | Twitter | Facebook
`
`
`
`Confidentiality Notice: The information contained in this email and any attachments to it may be legally privileged and
`include confidential information intended only for the recipient(s) identified above. If you are not one of those intended
`recipients, you are hereby notified that any dissemination, distribution or copying of this email or its attachments is strictly
`prohibited. If you have received this email in error, please notify the sender of that fact by return email and permanently
`delete the email and any attachments to it immediately. Please do not retain, copy or use this email or its attachments for
`any purpose, nor disclose all or any part of its contents to any other person. Andrews Kurth LLP operates as a limited
`liability partnership. Andrews Kurth (Middle East) DMCC is registered and licensed as a Free Zone company under the
`rules and regulations of DMCCA. Andrews Kurth (UK) LLP is authorized and regulated by the Solicitors Regulation
`Authority of England and Wales (SRA Registration No.598542). Thank you.
`
`1
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2034 - 1/1
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
